CRYOPORT, INC. Current Assets
CRYOPORT, INC. (CYRX) had Current Assets of $460.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-06
- 2026-06-30: Assets, Current $460.20M.
- 2026-03-31: Assets, Current $470.54M.
- 2025-12-31: Assets, Current $476.17M.
- 2025-09-30: Assets, Current $484.84M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $460.20M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $470.54M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $476.17M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $484.84M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $489.49M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $411.28M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $341.57M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $350.34M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $501.99M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $525.70M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $535.11M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $549.14M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $585.19M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $604.63M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $604.18M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $609.13M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $625.84M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $665.77M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $693.52M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $410.38M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $411.75M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $419.75M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $147.16M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $212.64M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $216.69M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $105.04M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $102.97M 10-K · filed 2021-03-01 | $102.96M 10-K · filed 2020-03-10 |
| 2019-09-30 | $102.22M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $101.67M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $52.45M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $51.77M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $27.94M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $24.23M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $22.04M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $17.30M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $17.22M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $14.49M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $16.39M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $6.10M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $4.25M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.91M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $4.13M 10-KT · filed 2017-03-13 | |
| 2015-12-31 | $6.21M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $8.03M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $3.51M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $2.16M 10-K · filed 2016-06-28 | |
| 2014-12-31 | $1.37M 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $655.54K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $783.39K 10-Q · filed 2014-07-31 | |
| 2014-03-31 | $1.11M 10-K · filed 2015-05-19 | |
| 2013-12-31 | $988.38K 10-Q · filed 2014-02-13 | |
| 2013-09-30 | $1.00M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | $823.11K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $958.30K 10-K · filed 2014-06-25 | |
| 2012-12-31 | $898.73K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $1.93M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $3.20M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $5.13M 10-K · filed 2013-06-25 | |
| 2011-12-31 | $3.06M 10-Q · filed 2012-02-21 | |
| 2011-09-30 | $5.36M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $7.66M 10-Q · filed 2011-08-15 | |
| 2011-03-31 | $10.00M 10-K · filed 2012-06-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |